Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

DORYX Drug Profile

« Back to Dashboard

What is the patent landscape for Doryx, and when can generic versions of Doryx launch?

Doryx is a drug marketed by Warner Chilcott, Mayne Pharma Intl, and Mayne Pharma. and is included in three NDAs. There are five patents protecting this drug and six Paragraph IV challenges.

This drug has two patent family members in two countries.

The generic ingredient in DORYX is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-two suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

Summary for Tradename: DORYX

Patents:2
Applicants:3
NDAs:3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list45
Clinical Trials: see list1
Patent Applications: see list1,332
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DORYX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott
DORYX
doxycycline hyclate
CAPSULE, DELAYED RELEASE;ORAL062653-001Oct 30, 1985DISCNNoNo► Subscribe► Subscribe
Mayne Pharma
DORYX MPC
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL050795-007May 20, 2016RXYesNo9,446,057► SubscribeY ► Subscribe
Mayne Pharma
DORYX MPC
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL050795-008May 20, 2016RXYesYes9,511,031► SubscribeY ► Subscribe
Mayne Pharma
DORYX
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL050795-001May 6, 2005ABRXYesNo8,715,724► SubscribeY ► Subscribe
Mayne Pharma
DORYX
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL050795-006Dec 19, 2014ABRXYesNo6,958,161► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot